Skip to main content
. Author manuscript; available in PMC: 2014 Sep 16.
Published in final edited form as: Cochrane Database Syst Rev. 2011 May 11;(5):CD003911. doi: 10.1002/14651858.CD003911.pub2

Comparison 6.

Nausea/vomiting

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 Grade 3 or more: 3 vs 24 hour infusion 2 948 Risk Ratio (IV, Random, 95% CI) 0.75 [0.24, 2.35]
1.1 Breast cancer 1 557 Risk Ratio (IV, Random, 95% CI) 0.41 [0.19, 0.88]
1.2 Ovarian cancer 1 391 Risk Ratio (IV, Random, 95% CI) 1.32 [0.67, 2.61]